{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:02:19Z","timestamp":1753887739935,"version":"3.41.2"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"DOI":"10.1542\/peds.2023-065328","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:05:21Z","timestamp":1715587521000},"source":"Crossref","is-referenced-by-count":1,"title":["The Promise of New Vaccines Against Respiratory Viruses"],"prefix":"10.1542","volume":"153","author":[{"given":"Robert L.","family":"Atmar","sequence":"first","affiliation":[{"name":"Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana M.","family":"El Sahly","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"issue":"40","key":"2024060102534705200_B1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.15585\/mmwr.mm7140a1","article-title":"Respiratory virus surveillance among children with acute respiratory illnesses \u2013 New Vaccine Surveillance Network, United States, 2016-2011","volume":"71","author":"Perez","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9773","key":"2024060102534705200_B2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","article-title":"Viral pneumonia","volume":"377","author":"Ruuskanen","year":"2011","journal-title":"Lancet"},{"issue":"34","key":"2024060102534705200_B3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"41","key":"2024060102534705200_B4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","article-title":"Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus\u2013associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024060102534705200_B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7202a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2023\u201324 influenza season","volume":"72","author":"Grohskopf","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"42","key":"2024060102534705200_B6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.15585\/mmwr.mm7242e1","article-title":"Use of updated COVID-19 vaccines 2023\u20132024 formula for persons aged \u22656 months: recommendations of the Advisory Committee on Immunization Practices\u2014United States, September 2023","volume":"72","author":"Regan","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"2024060102534705200_B7","doi-asserted-by":"crossref","first-page":"e2023064748","DOI":"10.1542\/peds.2023-064748","article-title":"Safety and immunogenicity of an mRNA-based hMPV\/PIV3 combination vaccine in seropositive children","volume":"153","author":"Ghamloush","year":"2024","journal-title":"Pediatrics"},{"issue":"6","key":"2024060102534705200_B8","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child"},{"issue":"3","key":"2024060102534705200_B9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/infdis\/jiad021","article-title":"A multicenter, controlled human infection study of influenza A(H1N1)pdm09 in healthy adults","volume":"228","author":"Ortiz","year":"2023","journal-title":"J Infect Dis"},{"issue":"6576","key":"2024060102534705200_B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"issue":"5","key":"2024060102534705200_B11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/vaccines10050819","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"6136","key":"2024060102534705200_B12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"6158","key":"2024060102534705200_B13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"7830","key":"2024060102534705200_B14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"issue":"1","key":"2024060102534705200_B15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"10068","key":"2024060102534705200_B16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"2024060102534705200_B17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"24","key":"2024060102534705200_B18","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV preF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"issue":"6622","key":"2024060102534705200_B19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"issue":"1","key":"2024060102534705200_B20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.idc.2021.11.010","article-title":"Update in the epidemiology, approaches to vaccine coverage and current outbreaks of measles","volume":"36","author":"Peart Akindele","year":"2022","journal-title":"Infect Dis Clin North Am"},{"issue":"33","key":"2024060102534705200_B21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15585\/mmwr.mm7133e2","article-title":"Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater \u2013 New York, June\u2013August 2022","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-065328\/1659087\/peds.2023-065328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-065328\/1659087\/peds.2023-065328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T02:54:27Z","timestamp":1717210467000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/153\/6\/e2023065328\/197264\/The-Promise-of-New-Vaccines-Against-Respiratory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,5,13]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2023-065328","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"article-number":"e2023065328"}}